Nat Med. 2014 Jul;20(7):695. doi: 10.1038/nm0714-695.
The 83 institutes and research facilities of the Max Planck Society, established in 1948, include some of the world's leading scholars in the life sciences, including 17 Noble Prize winners, and publish 15,000 research papers annually. For the past 18 years, biologists have stood at the helm of the prestigious German organization. But last month, an electrochemist and materials scientist, Martin Stratmann, began a six-year term as president of the Munich-based society.Stratmann, who is 60, served as the director of the Max Planck Institute for Iron Research in Düsseldorf since 2000, where he helped develop self-healing coatings that can protect steels and other metals from rust. Stratmann spoke with David Levine about his vision for the Max Planck Society and about what the change of guard will mean for biomedical research. The conversation has been edited for clarity.
马克斯·普朗克学会由 83 个研究所和研究机构组成,成立于 1948 年,拥有包括 17 名诺贝尔奖得主在内的世界领先的生命科学学者,每年发表 15000 篇研究论文。在过去的 18 年里,生物学家一直担任这家享有盛誉的德国组织的负责人。但在上个月,一位电化学家和材料科学家马丁·斯特拉曼(Martin Stratmann)开始了他在慕尼黑的马克斯·普朗克学会为期六年的主席任期。斯特拉曼现年 60 岁,自 2000 年以来一直担任杜塞尔多夫马克斯·普朗克钢铁研究所所长,在那里他帮助开发了可以保护钢和其他金属免受生锈的自修复涂层。斯特拉曼与大卫·莱文(David Levine)就他对马克斯·普朗克学会的愿景以及领导层的更迭将对生物医学研究意味着什么进行了交谈。此次谈话经过了编辑,以使其更加清晰。